The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients with neuroendocrine tumors (NETs), adrenal tumors, pheochromocytomas, paragangliomas, and multiple endocrine neoplasia. NETs are generally subclassified by site of origin, stage, and histologic characteristics. Appropriate diagnosis and treatment of NETs often involves collaboration between specialists in multiple disciplines, using specific biochemical, radiologic, and surgical methods. Specialists include pathologists, endocrinologists, radiologists (including nuclear medicine specialists), and medical, radiation, and surgical oncologists. These guidelines discuss the diagnosis and management of both sporadic and hereditary neuroendocrine and adrenal tumors and are intended to assist with clinical decision-making. This article is focused on the 2021 NCCN Guidelines principles of genetic risk assessment and counseling and recommendations for well-differentiated grade 3 NETs, poorly differentiated neuroendocrine carcinomas, adrenal tumors, pheochromocytomas, and paragangliomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J.-N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4377 · Cited by 4,510
Dasari, A., Shen, C., Halperin, D., Zhao, B., Zhou, S., Xu, Y., Shih, T., & Yao, J. C. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0589 · Cited by 3,447
Self-citationMarabelle, A., Le, D. T., Ascierto, P. A., Di Giacomo, A. M., De Jesus-Acosta, A., Delord, J.-P., Geva, R., Gottfried, M., Penel, N., Hansen, A. R., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02105 · Cited by 3,048
Self-citationFunder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Marabelle, A., Fakih, M., Lopez, J., Shah, M., Shapira-Frommer, R., Nakagawa, K., Chung, H. C., Kindler, H. L., Lopez-Martin, J. A., Miller, W. H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30445-9 · Cited by 2,552
Self-citationCONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
WHO Classification of Tumours of Endocrine Organs
김나래, Lloyd, Osamura, Rosai, & Klöppel, G. (2017) · Medical Entomology and Zoology · Cited by 1,600
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566 · cited 1×
“When malignanthyperaldosteronismissuspected,anopenadrenalectomy is recommended, because these tumors are prone to rupture.(89) Benign hyperaldosteronism is much more common and can be caused by a unilateral adrenal adenoma or bilateral adrenal hyperplasia.”
BackgroundTNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Histological Typing of Lung and Pleural Tumours
Travis, W. D., Colby, T. V., Corrin, B., Shimosato, Y., & Brambilla, E. (1999) · Springer eBooks · doi:10.1007/978-3-642-60049-4 · Cited by 1,523
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
Rindi, G., Klimstra, D. S., Abedi-Ardekani, B., Asa, S. L., Bosman, F. T., Brambilla, E., Busam, K. J., de Krijger, R. R., Dietel, M., El-Naggar, A. K., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0110-y · Cited by 1,163
McGrail, D. J., Pilié, P. G., Rashid, N. U., Voorwerk, L., Slagter, M., Kok, M., Jonasch, E., Khasraw, M., Heimberger, A. B., Lim, B., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.02.006 · Cited by 1,032
Sorbye, H., Welin, S., Langer, S. W., Vestermark, L. W., Holt, N., Osterlund, P., Dueland, S., Hofsli, E., Guren, M. G., Ohrling, K., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds276 · Cited by 1,027
Fassnacht, M., Dekkers, O. M., Else, T., Baudin, E., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assie, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 961
Rindi, G., Klöppel, G., Couvelard, A., Komminoth, P., Körner, M., Lopes, J. M., McNicol, A.-M., Nilsson, O., Perren, A., Scarpa, A., et al. (2007) · Virchows Archiv · doi:10.1007/s00428-007-0452-1 · Cited by 955
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Self-citationHalfdanarson, T. R., Rabe, K. G., Rubin, J., & Petersen, G. M. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn351 · Cited by 892
Self-citationCombination Chemotherapy in Advanced Adrenocortical Carcinoma
Fassnacht, M., Terzolo, M., Allolio, B., Baudin, E., Haak, H., Berruti, A., Welin, S., Schade-Brittinger, C., Lacroix, A., Jarzab, B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200966 · Cited by 873
Cancer: Principles and Practice of Oncology
CLAUDINO, W. M., & BIGANZOLI, L. (2007) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2006.00680.x · Cited by 855
Adrenal Masses: Characterization with Combined Unenhanced and Delayed Enhanced CT
Caoili, E. M., Korobkin, M., Francis, I. R., Cohan, R. H., Platt, J. F., Dunnick, N. R., & Raghupathi, K. I. (2002) · Radiology · doi:10.1148/radiol.2223010766 · Cited by 690
Chen, H., Sippel, R. S., O'Dorisio, M. S., Vinik, A. I., Lloyd, R. V., & Pacak, K. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb4f0 · Cited by 593
Yachida, S., Vakiani, E., White, C. M., Zhong, Y., Saunders, T., Morgan, R., de Wilde, R. F., Maitra, A., Hicks, J., DeMarzo, A. M., et al. (2012) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182417d36 · Cited by 534
Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors
Kulke, M. H., Stuart, K., Enzinger, P. C., Ryan, D. P., Clark, J. W., Muzikansky, A., Vincitore, M., Michelini, A., & Fuchs, C. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6046 · Cited by 513
Merino, D. M., McShane, L. M., Fabrizio, D., Funari, V., Chen, S.-J., White, J. R., Wenz, P., Baden, J., Barrett, J. C., Chaudhary, R., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000147 · Cited by 507
Zeiger, M. A., Thompson, G. B., Duh, Q.-Y., Hamrahian, A. H., Angelos, P., Elaraj, D., Fishman, E., Kharlip, J., Zeiger, M. A., Thompson, G. B., et al. (2009) · Endocrine Practice · doi:10.4158/ep.15.s1.1 · Cited by 499
Basturk, O., Yang, Z., Tang, L. H., Hruban, R. H., Adsay, V., McCall, C. M., Krasinskas, A. M., Jang, K.-T., Frankel, W. L., Balci, S., et al. (2015) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000408 · Cited by 482
Plouin, P. F., Amar, L., Dekkers, O. M., Fassnacht, M., Gimenez-Roqueplo, A. P., Lenders, J. W. M., Lussey-Lepoutre, C., Steichen, O., & _, _. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0033 · Cited by 480
Averbuch, S. D., Steakley, C. S., Young, R. C., Gelmann, E. P., Goldstein, D. S., Stull, R., & Keiser, H. R. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-4-267 · Cited by 427
Update in Adrenocortical Carcinoma
Fassnacht, M., Kroiss, M., & Allolio, B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3020 · Cited by 414
Pape, U., Jann, H., Müller‐Nordhorn, J., Bockelbrink, A., Berndt, U., Willich, S. N., Koch, M., Röcken, C., Rindi, G., & Wiedenmann, B. (2008) · Cancer · doi:10.1002/cncr.23549 · Cited by 405
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Zhuang, Z., Yang, C., Lorenzo, F., Merino, M., Fojo, T., Kebebew, E., Popovic, V., Stratakis, C. A., Prchal, J. T., & Pacak, K. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205119 · Cited by 397
Hochwald, S. N., Zee, S., Conlon, K. C., Colleoni, R., Louie, O., Brennan, M. F., & Klimstra, D. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.030 · Cited by 397
Panzuto, F., Nasoni, S., Falconi, M., Corleto, V. D., Capurso, G., Cassetta, S., Di Fonzo, M., Tornatore, V., Milione, M., Angeletti, S., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01017 · Cited by 391
Tang, L. H., Basturk, O., Sue, J. J., & Klimstra, D. S. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000662 · Cited by 382
Multiple Endocrine Neoplasia Type 1: Clinical and Genetic Topics
Marx, S., Spiegel, A. M., Skarulis, M. C., Doppman, J. L., Collins, F. S., & Liotta, L. A. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-6-199809150-00011 · Cited by 368
Tang, L. H., Untch, B. R., Reidy, D. L., O'Reilly, E., Dhall, D., Jih, L., Basturk, O., Allen, P. J., & Klimstra, D. S. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0548 · Cited by 352
Self-citationKlimstra, D. S., Modlin, I. R., Adsay, N. V., Chetty, R., Deshpande, V., Gönen, M., Jensen, R. T., Kidd, M., Kulke, M. H., Lloyd, R. V., et al. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181ce1447 · Cited by 351
Patel, S. P., Othus, M., Chae, Y. K., Giles, F. J., Hansel, D. E., Singh, P. P., Fontaine, A., Shah, M. H., Kasi, A., Baghdadi, T. A., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3356 · Cited by 345
Self-citationMAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Burnichon, N., Cascón, A., Schiavi, F., Morales, N. P., Comino-Méndez, I., Abermil, N., Inglada-Pérez, L., de Cubas, A. A., Amar, L., Barontini, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0160 · Cited by 331
Haak, H., Hermans, J., van de Velde, C., Lentjes, E., Goslings, B., Fleuren, G.-J., & Krans, H. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.183 · Cited by 329
Are G3 ENETS neuroendocrine neoplasms heterogeneous?
Vélayoudom-Céphise, F.-L., Duvillard, P., Foucan, L., Hadoux, J., Chougnet, C. N., Leboulleux, S., Malka, D., Guigay, J., Goere, D., Debaere, T., et al. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-13-0027 · Cited by 325
Pryma, D. A., Chin, B. B., Noto, R. B., Dillon, J. S., Perkins, S. M., Sólnes, L. B., Kostakoğlu, L., Serafini, A. N., Pampaloni, M. H., Jensen, J., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.217463 · Cited by 320
Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years
Hamidi, O., Young, W. F., Iñiguez-Ariza, N. M., Kittah, N. E., Gruber, L., Bancos, C., Tamhane, S., & Bancos, I. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00992 · Cited by 316
Berruti, A., Terzolo, M., Sperone, P., Pia, A., Della Casa, S., Gross, D. J., Carnaghi, C., Casali, P., Porpiglia, F., Mantero, F., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01025 · Cited by 308
Panzuto, F., Boninsegna, L., Fazio, N., Campana, D., Pia Brizzi, M., Capurso, G., Scarpa, A., De Braud, F., Dogliotti, L., Tomassetti, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0688 · Cited by 285
Dasari, A., Mehta, K., Byers, L. A., Sorbye, H., & Yao, J. C. (2018) · Cancer · doi:10.1002/cncr.31124 · Cited by 277
Baudin, E., Pellegriti, G., Bonnay, M., Penfornis, A., Laplanche, A., Vassal, G., & Schlumberger, M. (2001) · Cancer · doi:10.1002/1097-0142(20010915)92:6<1385::aid-cncr1461>3.0.co;2-2 · Cited by 239
Fishbein, L., Merrill, S., Fraker, D. L., Cohen, D. L., & Nathanson, K. L. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2942-5 · Cited by 238
p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies
Reincke, M. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.3.790 · Cited by 228
Gaujoux, S., Mihai, R., Carnaille, B., Dousset, B., Fiori, C., Porpiglia, F., Hellman, P., Iacobone, M., Kraimps, J.-L., Donatini, G., et al. (2017) · British Journal of Surgery · doi:10.1002/bjs.10414 · Cited by 226
Gicquel, C. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.6.1444 · Cited by 224
Konukiewitz, B., Schlitter, A. M., Jesinghaus, M., Pfister, D., Steiger, K., Segler, A., Agaimy, A., Sipos, B., Zamboni, G., Weichert, W., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.217 · Cited by 219
Gicquel, C., Raffin-Sanson, M.-L., Gaston, V., Bertagna, X., Plouin, P.-F., Schlumberger, M., Louvel, A., Luton, J.-P., & Le Bouc, Y. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4170 · Cited by 213
The Spectrum of Benefit from Checkpoint Blockade in Hypermutated Tumors
Rousseau, B., Foote, M. B., Maron, S. B., Diplas, B. H., Lu, S., Argilés, G., Cercek, A., & Diaz, L. A. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2031965 · Cited by 211
Hadoux, J., Favier, J., Scoazec, J., Leboulleux, S., Al Ghuzlan, A., Caramella, C., Déandreis, D., Borget, I., Loriot, C., Chougnet, C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28913 · Cited by 210
Adrenocortical carcinoma is a Lynch syndrome-associated cancer
Raymond, V. M., Everett, J. N., Furtado, L. V., Gustafson, S. L., Jungbluth, C. R., Gruber, S. B., Hammer, G. D., Stoffel, E. M., Greenson, J. K., Giordano, T. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.0988 · Cited by 208
Self-citationPD-1 Blockade in Advanced Adrenocortical Carcinoma
Raj, N., Zheng, Y., Kelly, V., Katz, S. S., Chou, J., Do, R. K. G., Capanu, M., Zamarin, D., Saltz, L. B., Ariyan, C. E., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01586 · Cited by 200
King, K. S., Prodanov, T., Kantorovich, V., Fojo, T., Hewitt, J. K., Zacharin, M., Wesley, R., Lodish, M., Raygada, M., Gimenez-Roqueplo, A.-P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.6353 · Cited by 196
van Hulsteijn, L. T., Niemeijer, N. D., Dekkers, O. M., & Corssmit, E. P. M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12341 · Cited by 193
Whole-Exome Sequencing Identifies MDH2 as a New Familial Paraganglioma Gene
Cascón, A., Comino-Méndez, I., Currás-Freixes, M., de Cubas, A. A., Contreras, L., Richter, S., Peitzsch, M., Mancikova, V., Inglada-Pérez, L., Pérez-Barrios, A., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv053 · Cited by 192
Gicquel, C. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.8.2559 · Cited by 184
Khan, T. S., Imam, H., Juhlin, C., Skogseid, B., Gröndal, S., Tibblin, S., Wilander, E., Öberg, K., & Eriksson, B. (2000) · Annals of Oncology · doi:10.1023/a:1008377915129 · Cited by 183
Strosberg, J. R., Weber, J. M., Feldman, M., Coppola, D., Meredith, K., & Kvols, L. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.5924 · Cited by 179
Self-citationThe molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors
Koch, C. A., Pacak, K., & Chrousos, G. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021069 · Cited by 177
Update on Modern Management of Pheochromocytoma and Paraganglioma
Lenders, J. W. M., & Eisenhofer, G. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.2.152 · Cited by 175
Klein, O., Kee, D., Markman, B., Michael, M., Underhill, C., Carlino, M. S., Jackett, L., Lum, C., Scott, C., Nagrial, A., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0621 · Cited by 174
Iwasa, S., Morizane, C., Okusaka, T., Ueno, H., Ikeda, M., Kondo, S., Tanaka, T., Nakachi, K., Mitsunaga, S., Kojima, Y., et al. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp173 · Cited by 170
Hentic, O., Hammel, P., Couvelard, A., Rebours, V, Zappa, M., Palazzo, M., Maire, F., Goujon, G., Gillet, A., Lévy, P., et al. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-12-0002 · Cited by 162
Ayala‐Ramirez, M., Feng, L., Habra, M. A., Rich, T., Dickson, P. V., Perrier, N., Phan, A., Waguespack, S., Patel, S., & Jimenez, C. (2012) · Cancer · doi:10.1002/cncr.26577 · Cited by 161
Self-citationvan Essen, M., Krenning, E. P., Kooij, P. P. M., Bakker, W. H., Feelders, R. A., de Herder, W. W., Wolbers, J. G., & Kwekkeboom, D. J. (2006) · PubMed · Cited by 161
van Hulsteijn, L. T., Dekkers, O. M., Hes, F. J., Smit, J. W. A., & Corssmit, E. P. M. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101192 · Cited by 160
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
Habra, M. A., Stephen, B., Campbell, M., Hess, K., Tapia, C., Xu, M., Rodon Ahnert, J., Jimenez, C., Lee, J. E., Perrier, N. D., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0722-x · Cited by 160
High‐dose 131I‐metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma
Rose, B., Matthay, K. K., Price, D., Huberty, J., Klencke, B., Norton, J. A., & Fitzgerald, P. A. (2003) · Cancer · doi:10.1002/cncr.11518 · Cited by 158
Evolution of the Primary Aldosteronism Syndrome: Updating the Approach
Vaidya, A., & Carey, R. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa606 · Cited by 158
Coriat, R., Walter, T., Terris, B., Couvelard, A., & Ruszniewski, P. B. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0476 · Cited by 156
Veytsman, I. G., Nieman, L. K., & Fojo, T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2775 · Cited by 154
New syndrome of paraganglioma and somatostatinoma associated with polycythemia.
Pacak, K., Jochmanová, I., Prodanov, T., Yang, C.-Z., Merino, M., Fojo, T., Prchal, J., Tischler, A., Lechan, R., & Zhuang, Z. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.1912 · Cited by 148
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma
Hadoux, J., Malka, D., Planchard, D., Scoazec, J., Caramella, C., Guigay, J., Boige, V., Leboulleux, S., Burtin, P. C., Berdelou, A., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0075 · Cited by 147
Turková, H., Prodanov, T., Malý, M., Martucci, V. L., Adams, K. T., Widimsky, J., Jr., Chen, C. C., Ling, A. L., Kebebew, E., Stratakis, C. A., et al. (2015) · Endocrine Practice · doi:10.4158/ep15725.or · Cited by 147
p53 Mutations in sporadic adrenocortical tumors
Ohgaki, H., Kleihues, P., & Heitz, P. U. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540310 · Cited by 139
Molecular Markers and the Pathogenesis of Adrenocortical Cancer
Soon, P. S. H., McDonald, K. L., Robinson, B. G., & Sidhu, S. B. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0243 · Cited by 139
Phase 2 study of pembrolizumab in patients with advanced rare cancers
Naing, A., Meric‐Bernstam, F., Stephen, B., Karp, D. D., Hajjar, J., Rodon, J. A., Piha-Paul, S. A., Colen, R. R., Jiménez, C., Raghav, K. P. S., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000347 · Cited by 139
Self-citationWilliams, T. A., & Reincke, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0990 · Cited by 131
Hereditary neuroendocrine tumors of the gastroenteropancreatic system
Anlauf, M., Garbrecht, N., Bauersfeld, J., Schmitt, A. M., Henopp, T., Komminoth, P., Heitz, P. U., Perren, A. A., & Klöppel, G. (2007) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-007-0450-3 · Cited by 128
Patel, S. P., Mayerson, E., Chae, Y. K., Strosberg, J., Wang, J., Konda, B., Hayward, J., McLeod, C. M., Chen, H. X., Sharon, E., et al. (2021) · Cancer · doi:10.1002/cncr.33591 · Cited by 128
Self-citationHamidi, O., Young, W. F., Gruber, L., Smestad, J. A., Yan, Q., Ponce, O. J., Prokop, L. J., Murad, M. H., & Bancos, I. (2017) · Clinical Endocrinology · doi:10.1111/cen.13434 · Cited by 124
Satapathy, S., Mittal, B. R., & Bhansali, A. K. (2019) · Clinical Endocrinology · doi:10.1111/cen.14106 · Cited by 121
Pfaff, W. W. (1998) · Head & Neck · doi:10.1002/(sici)1097-0347(199803)20:2<185::aid-hed16>3.0.co;2-l · Cited by 113
Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex
Am, L., Hedgire, S., Deshpande, V., Stemmer‐Rachamimov, A., Harisinghani, M., Ferrone, C., Shah, U. S., & Thiele, E. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01805.x · Cited by 109
Raymond, V. M., Else, T., Everett, J. N., Long, J. M., Gruber, S. B., & Hammer, G. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2198 · Cited by 105 · cited 2×
“8% of adults with ACC tested positive for Li Fraumeni syndrome (TP53 gene) and genetic testing should be routinely offered to all patients with ACC.(97) Another analysis found that approximately 3% of patients with ACC have Lynch syndrome, leading the authors to recommend that patients with ACC also undergo genetic te…”
BackgroundInfluentialRiccardo Autorino, B., Bove, P., SIO, M. D., Miano, R., Micali, S., Cindolo, L., Greco, F., Nicholas, J., Fiori, C., Bianchi, G., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4900-x · Cited by 105
Drugs and Pheochromocytoma — Don't Be Fooled by Every Elevated Metanephrine
Neary, N. M., King, K. S., & Pacák, K. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1101502 · Cited by 105
Analysis of 900 Appendiceal Carcinoid Tumors for a Proposed Predictive Staging System
Landry, C. S. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.7.664 · Cited by 102
Guignat, L., & Bertherat, J. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0627 · Cited by 101
Paragangliomas: Etiology, Presentation, and Management
Joynt, K. E., Moslehi, J. J., & Baughman, K. L. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e3181a6de40 · Cited by 100
Conzo, G., Musella, M., Corcione, F., Palma, M. D., Ferraro, F., Palazzo, A., Napolitano, S., Milone, M., Pasquali, D., Sinisi, A. A., et al. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2012.12.007 · Cited by 94
Use ofm-[131I]Iodobenzylguanidine in the Treatment of Malignant Pheochromocytoma
Krempf, M., Lumbroso, J., Mornex, R., Brendel, A., Wémeau, J.-L., Delisle, M. J., Aubert, B., CARPENTIER, P., Fleury-Goyon, M. C., Gibold, C., et al. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-455 · Cited by 91
Adrenocortical Carcinoma: Experience in 45 Patients
Barzon, L., Fallo, F., Sonino, N., Daniele, O., & Boscaro, M. (2009) · Oncology · doi:10.1159/000227608 · Cited by 83
Tanabe, A., Naruse, M., Nomura, K., Tsuiki, M., Tsumagari, A., & Ichihara, A. (2013) · Hormones and Cancer · doi:10.1007/s12672-013-0133-2 · Cited by 82
Tang, Y., Liu, Z., Zou, Z., Liang, J., Lu, Y., & Zhu, Y. (2018) · BioMed Research International · doi:10.1155/2018/9362108 · Cited by 77
Phaeochromocytoma: a catecholamine and oxidative stress disorder
Pacák, K. (2011) · Endocrine Regulations · doi:10.4149/endo_2011_02_65 · Cited by 76
Neuroendocrine Neoplasms of the Pancreas
Markow, M., & Centeno, B. A. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3426-3_13 · Cited by 74
A simplified prognostic system for resected pancreatic neuroendocrine neoplasms
Ballian, N., Loeffler, A. G., Rajamanickam, V., Norstedt, P., Weber, S. M., & Cho, C. S. (2009) · HPB · doi:10.1111/j.1477-2574.2009.00082.x · Cited by 64
Zhang, P., Li, J., Li, J., Zhang, X., Zhou, J., Wang, X., Peng, Z., Shen, L., & Lu, M. S. (2020) · Cancer · doi:10.1002/cncr.32750 · Cited by 64
Marchevsky, A. M., Hendifar, A. E., & Walts, A. E. (2018) · Modern Pathology · doi:10.1038/s41379-018-0076-9 · Cited by 59
A Proposed Staging System for Gastric Carcinoid Tumors Based on an Analysis of 1,543 Patients
Landry, C. S., Brock, G. N., Scoggins, C. R., McMasters, K. M., & Martin, R. C. G. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0192-8 · Cited by 58
Frizziero, M., Spada, F., Lamarca, Á., Kordatou, Z., Barriuso, J., Nuttall, C., McNamara, M. G., Hubner, R. A., Mansoor, W., Manoharan, P., et al. (2019) · Neuroendocrinology · doi:10.1159/000497336 · Cited by 50
Yoshinaga, K., Oriuchi, N., Wakabayashi, H., Tomiyama, Y., Jinguji, M., Higuchi, T., Kayano, D., Fukuoka, M., Inaki, A., Toratani, A., et al. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0211 · Cited by 48
Rogowski, W., Wachuła, E., Gorzelak-Magiera, A., Lebiedzińska, A., Sulżyc-Bielicka, V., Iżycka‐Świeszewska, E., Żołnierek, J., & Kos‐Kudła, B. (2019) · Endokrynologia Polska · doi:10.5603/ep.a2019.0010 · Cited by 46
Sahu, A., Jefford, M., Lai-Kwon, J. E., Thai, A. A., Hicks, R. J., & Michael, M. (2019) · Journal of Oncology · doi:10.1155/2019/9032753 · Cited by 44
Genetic predisposition to endocrine tumors: Diagnosis, surveillance and challenges in care
Petr, E. J., & Else, T. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.08.007 · Cited by 40
Li, X., Gou, S., Liu, Z., Zeng, Y., & Wang, C. (2018) · Cancer Medicine · doi:10.1002/cam4.1336 · Cited by 36
Wang, W., Li, P., Wang, Y., Wang, Y., Ma, Z., Wang, G., Gao, J., & Zhou, H. (2015) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2014.11.012 · Cited by 32
Lynch, H. T., Radford, B., & Lynch, J. F. (2009) · Oncology · doi:10.1159/000226789 · Cited by 28
Are Neuroendocrine Tumors Going Mainstream?
Kulke, M. H. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.3884 · Cited by 12
Predictors of outcome in phaeochromocytomas and paragangliomas
Nicolas, M. M., & Dahia, P. L. M. (2017) · F1000Research · doi:10.12688/f1000research.12419.1 · Cited by 8
Combining Washout and Noncontrast Data From Adrenal Protocol CT
Ng, C. S., Altınmakas, E., Wei, W., Ghosh, P., Li, X., Grubbs, E. G., Perrier, N. A., Prieto, V. G., Lee, J. E., & Hobbs, B. P. (2018) · Academic Radiology · doi:10.1016/j.acra.2017.12.005 · Cited by 7
Cited by
Zhang, N., Li, R.-H., Ma, L., Li, N., Shan, P.-Y., Wang, X.-B., & Liu, A.-F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00001 · Cited by 490
Radiolabeled somatostatin analogs-a continuously evolving class of radiopharmaceuticals.
Fani, M., Mansi, R., Nicolas, G. P., & Wild, D. (2022) · Cancers · doi:10.3390/cancers14051172 · Cited by 56
Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives
Modica, R., Liccardi, A., Minotta, R., Cannavale, G., Benevento, E., & Colao, A. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2099840 · Cited by 37
Yang, K., Li, J., Cheng, Y., & Bai, C. (2023) · Endocrine Connections · doi:10.1530/ec-22-0441 · Cited by 4
Metadata
- Authors
- Shah, M. H., Goldner, W. S., Benson, A. B., Bergsland, E., Blaszkowsky, L. S., Brock, P., Chan, J., Das, S., Dickson, P. V., Fanta, P., Giordano, T., Halfdanarson, T. R., Halperin, D., He, J., Heaney, A., Heslin, M. J., Kandeel, F., Kardan, A., Khan, S. A., Kuvshinoff, B. W., Lieu, C., Miller, K., Pillarisetty, V. G., Reidy, D., Salgado, S. A., Shaheen, S., Soares, H. P., Soulen, M. C., Strosberg, J. R., Sussman, C. R., Trikalinos, N. A., Uboha, N. A., Vijayvergia, N., Wong, T., Lynn, B., & Hochstetler, C.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2021-07
- Volume
- 19
- Issue
- 7
- Pages
- 839-868
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W3192494717
- Cited by
- 619
- References
- 123
- FWCI
- 59.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.